Why Is Intuitive Surgical (ISRG) Stock Falling Despite an Earnings Beat?

TLDR Intuitive Surgical (ISRG) stock fell about 8% in premarket trading to around $405 on Wednesday after Q3 results. Adjusted EPS of $3.00 beat the $2.65 estimate, and revenue of $3.05 billion topped the $2.91 billion forecast. A $450 million antitrust settlement cut GAAP net income to $523 million, or $1.49 per diluted share. Management said instrument pricing cuts will lower revenue per procedure by about 3% to 5% once fully in place in 2027. U.S. procedure growth slowed to 10%, and the 2026 worldwide growth forecast was narrowed to 14% to 15%. Intuitive Surgical (ISRG) stock fell about 8% in premarket trading on Wednesday, dropping to roughly $405. The move came after the company reported third-quarter results that beat Wall Street estimates but carried a $450 million legal charge.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to CoinCentral.